Healthcare

Compumedics Secures $20M in Chinese MEG Sales as Demand for Brain Im...

Highlights,$20M in MEG system sales achieved in China,Latest $5.7M deal signed with Hangzhou Normal University,Growing momentum signals strong future...

Nanosonics Shares Surge After US Approval, But Analysts Urge Caution...

Highlights,Nanosonics shares jump after US FDA greenlight,CORIS tool sees early investor excitement,Analysts flag slow rollout and valuation concerns,...

Can Cochlear (ASX:COH) Regain Momentum in 2025? Here’s What the Numb...

Highlights,Revenue growth averaging 14.3% per year over 3 years,Strong gross margin of 74.9% and healthy net profit,Low debt levels and solid return o...

MedAdvisor Limited's (ASX:MDR) Stock Performance: A Deep Dive

Highlights,MedAdvisor Limited (ASX:MDR) has seen a significant stock price drop.,The company’s growth forecasts are lagging behind the industry.,Reven...

ResMed (ASX:RMD) A Closer Look at Its Market Performance and Growth...

Highlights,ResMed’s Market Movement,: Shares of ResMed (RMD) have declined by 4.6% since the start of 2025.,Healthcare Industry Resilience,: The secto...

FDA Greenlights Telix’s Advanced Prostate Cancer Imaging Agent, Goze...

Highlights,FDA approves,Telix’s,next-gen prostate cancer imaging agent,Gozellix,® offers wider access through extended shelf life,Reimbursement eligib...

Reviving Potential: How Race Oncology’s Breakthrough Could Redefine...

Highlights,Race Oncology brings back a shelved cancer drug with modern innovation,New formulation offers 20 years of exclusive patent protection,Poten...

Anteris Technologies' DurAVR® Transcatheter Valve Shows Strong One-Y...

Highlights,DurAVR,® THV continues to,demonstrate,exceptional durability and hemodynamic performance.,No cases of prosthesis-patient mismatch (PPM) wer...

Understanding the Dynamics Behind Immutep Limited's (ASX:IMM) Shareh...

Highlights,Institutional investors hold the majority shares in Immutep Limited (IMM).,The top seven investors control over 50% of the company's stock....

Is Red Metal (ASX:RDM) Making Wise Decisions with Its Cash?

Highlights,Red Metal shows a 14-month cash runway as of December 2024.,Cash burn reduced by 6% year over year.,Future cash raises may lead to sharehol...

Rhythm Biosciences (ASX:RHY) Celebrates Milestone with Initial Comme...

Highlights,First commercial sales recorded for,geneType,products.,Strategic growth targeted in enterprise and global markets.,Anticipation builds for...

Market Cautious on Doctor Care Anywhere Group (ASX:DOC) Despite Low...

Highlights,Doctor Care Anywhere Group sports a notably low P/S ratio.,Recent revenue trends fall short compared to industry growth.,Future revenue pro...

Optimism in the Australian Healthcare Sector: Analysts Highlight CSL...

Highlights,Positive outlook for CSL (CSL) and ResMed (RMD).,Balanced prospects for other healthcare stocks.,Caution,advised,for Ramsay Health Care and...

We Don't Have Major Concerns Regarding LTR Pharma's (LTP) Cash Burn...

Highlights:,LTR Pharma maintains a strong cash position with no outstanding debt.,Recent cash burn increase attributed to operational expansion.,Futur...

Imricor Medical Systems (ASX:IMR) Trading Halted Ahead of Capital Ra...

Highlights,Imricor,(IMR) shares suspended ahead of capital raising announcement.,Trading halt in effect until company provides details.,Imricor,plans...

Emvision's Remote Stroke Detection Breakthrough and Biotech Sector D...

Highlights,Emvision Medical Devices (EMV) initiates trial for innovative remote stroke detection technology.,Despite challenging market conditions, se...

Syntara (ASX:SNT) shareholders have experienced remarkable returns,...

Highlights,SNT shares soared by an impressive 305% over the past year.,Recent financial results indicate significant revenue growth.,Long-term shareho...

Pro Medicus Limited (ASX:PME) have recently been purchasing more sha...

Highlights,Insiders hold 49% of ASX:PME shares, indicating significant vested interests.,Top 4 shareholders control 51% of the company, influencing ke...

Orthocell (ASX:OCC) Expands Global Footprint with Singapore Approval...

Highlights,Singapore’s Health Sciences Authority grants approval for Striate+,Global sales growth continues with strong adoption rates,Expansion effor...

CLEO Diagnostics initiates the transfer of intellectual property for...

Highlights:,CLEO Diagnostics progresses with technology transfer for its ovarian cancer blood test.,Collaboration with R&D Systems Inc supports antibo...